Cardiol Therapeutics (CRDL) Change in Inventory (2020)

Cardiol Therapeutics (CRDL) posted Change in Inventory of $711198.5 for Q4 2020.

Cardiol Therapeutics (CRDL) Change in Inventory (2020) Analysis & Trends

Cardiol Therapeutics' Change in Inventory history runs 1 years deep, the most recent figure standing at $711198.5 for Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -93.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 114.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 119.24 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 40.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 123.00 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -4.30 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Cardiol Therapeutics 134.05 Mn 134.05 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 711,198.51
Dec 31, 2020 711,198.51